Business Wire

Phenom Named Strategic Leader in Fosway 9-Grid™ for Talent Acquisition 2024 for Fourth Consecutive Year


Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. Fosway identifies Strategic Leaders as companies that provide a rich suite of capability across a broad scope of features and have the sophistication to consistently meet the needs of complex enterprise-scale customers. Strategic Leaders are also recognised by Fosway for having strong market performance and customer advocacy; as a result, they are frequently selected by such organisations and consistently meet their needs.

This press release features multimedia. View the full release here:

To view this piece of content from, please give your consent at the top of this page.

Phenom has been named a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition for the fourth consecutive year, demonstrating the comprehensive nature of its solution and its ability to innovate, drive business impact, and support with customer adoption and satisfaction compared to alternative talent acquisition software solutions. (Graphic: Business Wire)

The European job market is undergoing a significant transformation. Challenges such as talent shortages and technological disruptions are actively shaping the dynamics of recruitment practices. To navigate this, talent acquisition leaders, sourcers, talent marketers, recruitment events managers, and recruiters must adopt a multifaceted approach that encompasses building alliances, appropriately leveraging and consolidating technology, personalising candidate engagement, maximising utilisation of artificial intelligence and automation, and embracing data insights.

“The TA industry faces many challenges due to a fragmented tech stack, and companies often struggle to streamline their recruitment processes and engage candidates effectively,” said David Wilson, CEO and founder of Fosway Group. “Phenom’s Intelligent Talent Experience platform aims to deliver an effective, data-driven, personalised enterprise solution to these issues. Their continued innovation and customer outcomes are reflected in their position as a Strategic Leader for a fourth successive year.”

The Most Productive, Efficient Organisations Will Define the Decade Ahead

More than 600 global, diverse enterprises use Phenom’s automations, intelligence, and experience to achieve measurable, defensible results, including the ability to:

“Phenom's fourth consecutive year being recognised as a Strategic Leader in the 2024 Fosway 9-Grid™ for Talent Acquisition reaffirms our commitment to innovation, customer impact, and advocacy,” said John Harrington, Senior Director, Product Marketing at Phenom. “Securing the highest positioning in performance and potential is a testament to our 13+ years in the industry and reflects our ability to partner with global organisations across all industries to address their unique challenges and exceed their goals.”

Leading the Way in Generative AI Adoption and Impact in HR

The advent of generative AI in the past year afforded Phenom a significant opportunity to address the challenges being experienced by its customers with immediate solutions that drive efficiency and productivity outcomes. Since its introduction in 2023, Phenom X+ Generative AI in Phenom’s Intelligent Talent Experience platform has been adopted by over 600 customers, supporting over 60 use cases, and saving HR teams 37,000 hours in the process. Top X+ generative AI use cases and examples of time savings include:

  • Email generation, saving Talent CRM users over 6 minutes per email
  • Generation of profile summaries, affording 15 hours back to talent acquisition teams each week
  • Development of SMS and email campaigns, leading to 35% higher response rates from candidates

Unleashing a Massive Wave of HR Tech Innovation

Phenom continues to innovate by introducing new functionality and capabilities intended to address the top challenges being experienced by talent practitioners today.

2024 Phenom platform innovation highlights include:

  • Talent Experience Engine: transforms talent marketers into strategists by leveraging large datasets to create personalised, on-brand campaigns. It enhances efficiency by unifying persona and journey data, enabling content creation, segment identification, personalised journeys, and automated outreach. This comprehensive set of tools optimises engagement and conversion for candidates, employees, and alumni.
  • X+ Source: optimises sourcing by segmenting talent pools and creating personalised journeys to attract best-fit candidates. Simply request candidates for a specific role and location, and X+ Source finds the best-fit talent, provides recommendations, summarises key details, and conducts automatic outreach to establish initial contact.
  • X+ Workforce Intelligence: connects data from employees, management, HR teams, candidates, and recruiters to provide real-time talent insights for proactive retention and growth. HR teams and managers can identify skills gaps, create personalised development plans, and designate successors based on data to find ideal candidates.
  • Talent Marketer Experience: empowers talent marketers to craft personalised content, design campaigns, segment talent, and engage effectively using AI and automation. X+ Agents guide marketers through tasks, enhancing engagement throughout the talent lifecycle via a single, unified platform.
  • Talent Leader Experience: provides recruitment managers with organisation-wide insights and individual performance data, including requisition and candidate interaction metrics. X+ Agents offer tailored action plans based on hiring type, enhancing team efficiency and effectiveness.
  • X+ Screening: enables fast, intelligent hiring decisions by offering comprehensive insights based on recorded answers, situational judgment questions, and call simulations for all job types.
  • Structured Interviews: streamlines interview processes with automated note-taking, question management, and real-time transcription. It enables hiring teams to focus on meaningful candidate interactions while reducing human error and leveraging AI for confident hiring decisions through organised and analysed data.
  • Contingent Talent Hiring: helps top brands attract contractors effortlessly via Phenom. Companies can now seamlessly discover and hire temporary workers, with integrated support for Vendor Management Systems and payroll providers for smooth onboarding.
  • Events Pro: streamlines event creation to easily target demographics through email, SMS, and registration forms. Personalised virtual event lobbies allow talent to review content, visit booths, and receive automatic event summaries via email.
  • Phenom Assessments: have expanded the existing behavioral and language assessments to include motivation and interest assessments to guide early talent to the right jobs.
  • X+ Fit Score: enables talent acquisition professionals to extend the typical criteria used to formulate fit scores, or customise the scores in the context of the role.

Companies across EMEA are successfully adopting Phenom’s Intelligent Talent Experience platform to help candidates find and choose the right job faster, employees develop their skills and evolve, recruiters become wildly productive, talent marketers engage with extreme efficiency, talent leaders optimise hiring processes, managers build stronger-performing teams, HR align employee development with company goals, and HRIS easily integrate existing HR tech to create a holistic infrastructure.

On June 6, Phenom is demonstrating its massive wave of recent platform innovations during its HR Innovation Showcase. Register here for the streaming event and see how Phenom continues to innovate, earning its position as a Strategic Leader for the fourth consecutive year.

About the Fosway 9-Grid™

Fosway Group is Europe’s #1 HR industry analyst. The Fosway 9-Grid™ provides a unique assessment of the principal learning and talent supply options available to organisations in EMEA. The analysis is based on extensive independent research and insights from Fosway’s Corporate Research Network of over 250 organisations, including BP, HSBC, PwC, RBS, Sanofi, Shell, and Vodafone. Visit the Fosway website at

About Phenom

Phenom has a purpose of helping a billion people find the right work. Through AI-powered talent experiences, employers use Phenom to hire employees faster, develop them to their full potential, and retain them longer. The Phenom Intelligent Talent Experience platform seamlessly connects candidates, employees, recruiters, talent marketers, talent leaders, hiring managers, HR and HRIS — empowering diverse and global enterprises with innovative products including Phenom X+ Generative AI, Career Site, Chatbot, CMS, Talent CRM, One-Way Interviews, Automated Interview Scheduling, Interview Intelligence, Talent Experience Engine, Campaigns, University Recruiting, Contingent Talent Hiring, Talent Marketplace, Workforce Intelligence, Career Pathing, Gigs, Mentoring, and Referrals.

Phenom has earned accolades including: Inc. 5000’s fastest-growing companies (4 consecutive years), Deloitte Technology's Fast 500 (4 consecutive years), five Brandon Hall ‘Excellence in Technology’ awards including Gold for ‘Best Advance in AI for Business Impact,’ Business Intelligence Group's Artificial Intelligence Excellence Awards (3 consecutive years), and a regional Timmy Award for launching and optimizing (2020).

Headquartered in Greater Philadelphia, Phenom also has offices in India, Israel, the Netherlands, Germany and the United Kingdom.

For more information, please visit Connect with Phenom on LinkedIn, Twitter, Facebook, YouTube and Instagram.

To view this piece of content from, please give your consent at the top of this page.

Contact information

Jennifer Lyons

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

DentalMonitoring Sets New Standard in Orthodontic Remote Monitoring With EU-MDR Certification14.6.2024 19:33:00 CEST | Press release

DentalMonitoring is proud to announce that the DentalMonitoring Software is now certified under the European Union Medical Device Regulation 2017/745 (EU MDR) and fulfills the requirements for CE marking as a class IIa medical device. European Medical Device Regulation 2017/745 (EU MDR) replaces the previous Medical Device Directive 93/42/EEC (MDD). EU MDR sets more rigorous requirements for clinical evaluation, risk management, post-market surveillance, and data collection on medical devices.(1) This landmark achievement underscores DentalMonitoring's commitment to advancing dental care through cutting-edge technology and rigorous regulatory compliance. Achieving this certification four years ahead of the deadline demonstrates DentalMonitoring's commitment to positioning itself as an innovative, serious, efficient, and safe player in the medical field. This press release features multimedia. View the full release here: DentalMo

Argonne and a Moroccan University Sign Agreement to Advance Green Energy Tech and Computing14.6.2024 15:24:00 CEST | Press release

The U.S. Department of Energy’s (DOE) Argonne National Laboratory and University Mohammed VI Polytechnic (UM6P) have signed a memorandum of understanding (MOU) to collaborate on key areas of mutual interest related to green energy technology and the nexus of water and energy. In a ceremony held at UM6P’s campus in Benguerir, the MOU was signed by Argonne Laboratory Director Paul Kearns and UM6P President Hicham El Habti. “We are excited to see what discoveries and innovations will result from our ongoing partnership,” said Kearns. ​“By working together, we’ll open new scientific frontiers for both our countries’ futures.” “Today marks a significant milestone in our journey towards sustainable innovation. The signing of this Memorandum of Understanding with Argonne National Laboratory underscores our commitment to advancing research and development in renewable energy, energy grids, and water management. Together, we aim to leverage our collective expertise to create transformative solu

MultiBank Group Recognized as Top BaFin-Regulated Forex Broker14.6.2024 14:33:00 CEST | Press release

MultiBank Group is thrilled to announce its recognition as a top BaFin-regulated forex broker by FXEmpire, a leading financial markets authority. This prestigious accolade highlights MultiBank Group's unwavering commitment to excellence, security, and innovation in the forex trading industry. This press release features multimedia. View the full release here: Top BaFin regulated forex broker 2024 (Graphic: Business Wire) About BaFin: Regulating German Financial Markets BaFin, Germany's Federal Financial Supervisory Authority, oversees the country's banking, securities, and insurance sectors. It ensures fair and transparent operations in the forex and CFD markets by enforcing rigorous standards. Selection Methodology FXEmpire's methodology for selecting the best BaFin-regulated brokers includes: Regulation Verification: Ensuring each broker is BaFin-regulated, providing traders with high-level protection. Cost Efficiency: Brokers

Takeda Signs Option Agreement with Ascentage Pharma to Enter into Exclusive Global License for Olverembatinib, a Third-Generation BCR-ABL Tyrosine Kinase Inhibitor (TKI)14.6.2024 14:00:00 CEST | Press release

Takeda (TSE:4502/NYSE:TAK) today announced the signing of an option agreement with Ascentage Pharma to enter into an exclusive license agreement for olverembatinib, an oral, potentially best-in-class, third-generation BCR-ABL tyrosine kinase inhibitor (TKI), which is currently in development for chronic myeloid leukemia (CML) and other hematological cancers. If exercised, the option would allow Takeda to license global rights to develop and commercialize olverembatinib in all territories outside of mainland China, Hong Kong, Macau, Taiwan and Russia. Despite the impact TKIs have had in the treatment of patients with CML, there remains significant unmet need for patients whose disease is resistant or refractory to these therapies or who develop hard-to-treat mutations following these treatments. “Takeda has a long history of driving important treatment advances for patients, particularly those with hematological cancers facing treatment gaps,” said Teresa Bitetti, president of the Globa

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye